RenaissanceRe (NYSE:RNR) Stock Price Expected to Rise, Barclays Analyst Says

RenaissanceRe (NYSE:RNR) had its target price increased by investment analysts at Barclays from $310.00 to $341.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the insurance provider’s stock. Barclays‘s price objective would indicate a potential upside of 10.05% from the stock’s previous close.

RNR has been the subject of a number of other reports. Evercore upped their price target on RenaissanceRe from $283.00 to $291.00 and gave the company an “in-line” rating in a research report on Wednesday, February 4th. Zacks Research lowered RenaissanceRe from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 6th. Weiss Ratings restated a “buy (b)” rating on shares of RenaissanceRe in a research report on Friday, March 27th. Citigroup increased their price objective on RenaissanceRe from $328.00 to $333.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 18th. Finally, Wells Fargo & Company increased their price objective on RenaissanceRe from $281.00 to $306.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 5th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $309.50.

RenaissanceRe Price Performance

RNR stock opened at $309.87 on Wednesday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.43 and a quick ratio of 1.43. The business has a 50 day simple moving average of $297.92 and a 200-day simple moving average of $276.20. The firm has a market capitalization of $13.37 billion, a PE ratio of 5.47, a price-to-earnings-growth ratio of 0.71 and a beta of 0.24. RenaissanceRe has a 1 year low of $222.75 and a 1 year high of $315.88.

RenaissanceRe (NYSE:RNR) last posted its quarterly earnings results on Tuesday, February 3rd. The insurance provider reported $13.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.59 by $2.75. The business had revenue of $2.97 billion during the quarter, compared to analyst estimates of $1.73 billion. RenaissanceRe had a return on equity of 18.29% and a net margin of 20.88%.The business’s revenue was up 29.6% compared to the same quarter last year. During the same period in the prior year, the business earned $8.06 earnings per share. Equities research analysts anticipate that RenaissanceRe will post 26.04 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Robert Qutub sold 5,000 shares of the stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $305.75, for a total value of $1,528,750.00. Following the completion of the transaction, the executive vice president directly owned 73,023 shares in the company, valued at approximately $22,326,782.25. This represents a 6.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 2.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. Capital World Investors boosted its position in shares of RenaissanceRe by 0.3% during the third quarter. Capital World Investors now owns 2,649,518 shares of the insurance provider’s stock worth $672,792,000 after buying an additional 7,839 shares during the period. Boston Partners boosted its position in shares of RenaissanceRe by 9.9% during the fourth quarter. Boston Partners now owns 1,423,483 shares of the insurance provider’s stock worth $400,150,000 after buying an additional 128,245 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of RenaissanceRe by 3.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,033,009 shares of the insurance provider’s stock worth $290,450,000 after buying an additional 31,599 shares during the period. Lightrock Netherlands B.V. boosted its position in shares of RenaissanceRe by 4,690.1% during the fourth quarter. Lightrock Netherlands B.V. now owns 1,017,508 shares of the insurance provider’s stock worth $286,083,000 after buying an additional 996,266 shares during the period. Finally, Bank of America Corp DE boosted its position in shares of RenaissanceRe by 17.6% during the second quarter. Bank of America Corp DE now owns 803,547 shares of the insurance provider’s stock worth $195,182,000 after buying an additional 120,063 shares during the period. 99.97% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about RenaissanceRe

Here are the key news stories impacting RenaissanceRe this week:

• Positive Sentiment: Cantor Fitzgerald upgraded RNR from Neutral to Overweight and raised its target to $340, signaling meaningful upside and helping support the rally. Cantor Fitzgerald Upgrade (Benzinga) Finviz
• Positive Sentiment: Barclays raised its price target sharply to $341 (from $310) while keeping an Equal Weight rating — a sizable lift to consensus targets that likely boosted investor optimism. Barclays PT Raise (Benzinga)
• Positive Sentiment: UBS bumped its target to $319 and reiterated a Neutral view, adding incremental upward pressure on the stock by increasing modeled value. UBS PT Raise (Benzinga)
• Positive Sentiment: Keefe, Bruyette & Woods published a note forecasting strong price appreciation for RNR, which reinforces buy-side thesis around underwriting leverage and capital return. Keefe, Bruyette & Woods Forecast
• Positive Sentiment: Zacks / industry commentary highlighted RNR among P&C insurers positioned to benefit from digitalization and pricing tailwinds after catastrophe activity — a sector-level bullish signal for premiums and renewals. Zacks Industry Outlook (Yahoo)
• Positive Sentiment: A Zacks piece listing “5 Stocks to Add From the Prospering P&C Insurance Industry” included RNR, reinforcing positive thematic interest from value and sector investors. Zacks: 5 P&C Stocks
• Neutral Sentiment: Zacks published an analysis asking whether value investors should buy RNR, providing balanced coverage that may attract research-driven flows but not an explicit buy signal. Zacks Stock Analysis
• Neutral Sentiment: AmericanBankingNews noted that brokerages’ consensus rating is roughly a “Hold,” which caps upside expectations until more positive revisions arrive. Brokerage Consensus (AmericanBankingNews)
• Neutral Sentiment: CNN Markets maintains a standard company profile page for RNR (useful for quote/activity context but not new directional news). CNN Markets: RNR
• Negative Sentiment: Wells Fargo trimmed its price target slightly from $306 to $305 and kept an Equal Weight rating — a modest negative signal that partially offsets the bullish broker activity. Wells Fargo PT Cut (Benzinga)

About RenaissanceRe

RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance solutions, specializing in property catastrophe, casualty, and specialty lines. Established in 1993 and headquartered in Bermuda, the company trades on the New York Stock Exchange under the symbol RNR. With a focus on underwriting and risk assessment, RenaissanceRe offers tailored programs designed to help insurers and corporations manage exposure to natural disasters, liability claims, and other complex risks.

The company operates through two primary segments: Reinsurance and Insurance.